(Post-pandemic Era)-Global Therapeutic Radioisotopes Market Segment Research Report 2022
- Published Date: 2022-04-19
- Report ID: 128377
- Pages: 175
-
Format:
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. XYZResearchreleased the Global Therapeutic Radioisotopes Market Segment Research Report 2022, which aims to sort out the development status and trends of the Therapeutic Radioisotopes industry at home and abroad, estimate the overall market scale of the Therapeutic Radioisotopes industry and the market share of major countries, analyze the development potential of each segment of the Therapeutic Radioisotopes industry, and study and judge the downstream market demand of Therapeutic Radioisotopes through systematic research, Analyze the competition pattern of Therapeutic Radioisotopes, so as to help solve the pain points of various stakeholders in Therapeutic Radioisotopes industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of Therapeutic Radioisotopes Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Therapeutic Radioisotopes Market
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes
Major Type of Therapeutic Radioisotopes Covered in XYZResearch report:
Radium-223
Lutetium-177
Iodine-131
Other
Application Segments Covered in XYZResearch Market
Thyroid
Bone Metastasis
Lymphoma
Other
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Therapeutic Radioisotopes Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Therapeutic Radioisotopes Market by Value
2.2.1 Global Therapeutic Radioisotopes Revenue by Type
2.2.2 Global Therapeutic Radioisotopes Market by Value (%)
2.3 Global Therapeutic Radioisotopes Market by Production
2.3.1 Global Therapeutic Radioisotopes Production by Type
2.3.2 Global Therapeutic Radioisotopes Market by Production (%)
3. The Major Driver of Therapeutic Radioisotopes Industry
3.1 Historical & Forecast Global Therapeutic Radioisotopes Demand
3.2 Largest Application for Therapeutic Radioisotopes (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Therapeutic Radioisotopes Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2019-2027)
4.3 Concentration Ratio (CR5& CR10) of Therapeutic Radioisotopes Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Therapeutic Radioisotopes Production, Demand (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Therapeutic Radioisotopes Production, Demand (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Therapeutic Radioisotopes Production, Demand (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Therapeutic Radioisotopes Production, Demand (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Therapeutic Radioisotopes Production, Demand (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Therapeutic Radioisotopes Production, Demand (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Therapeutic Radioisotopes Production, Demand (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Therapeutic Radioisotopes Average Price Trend
12.1 Market Price for Each Type of Therapeutic Radioisotopes in US (2018-2022)
12.2 Market Price for Each Type of Therapeutic Radioisotopes in Europe (2018-2022)
12.3 Market Price for Each Type of Therapeutic Radioisotopes in China (2018-2022)
12.4 Market Price for Each Type of Therapeutic Radioisotopes in Japan (2018-2022)
12.5 Market Price for Each Type of Therapeutic Radioisotopes in India (2018-2022)
12.6 Market Price for Each Type of Therapeutic Radioisotopes in Korea (2018-2022)
12.7 Market Price for Each Type of Therapeutic Radioisotopes in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
13.1 Therapeutic Radioisotopes Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Technology Trends of Therapeutic Radioisotopes
14. Therapeutic Radioisotopes Competitive Landscape
14.1 Bayer
14.1.1 Bayer Company Profiles
14.1.2 Bayer Product Introduction
14.1.3 Bayer Therapeutic Radioisotopes Sales, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Novartis
14.2.1 Novartis Company Profiles
14.2.2 Novartis Product Introduction
14.2.3 Novartis Therapeutic Radioisotopes Sales, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 China Isotope & Radiation
14.3.1 China Isotope & Radiation Company Profiles
14.3.2 China Isotope & Radiation Product Introduction
14.3.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Dongcheng
14.4.1 Dongcheng Company Profiles
14.4.2 Dongcheng Product Introduction
14.4.3 Dongcheng Therapeutic Radioisotopes Sales, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Q BioMed
14.5.1 Q BioMed Company Profiles
14.5.2 Q BioMed Product Introduction
14.5.3 Q BioMed Therapeutic Radioisotopes Sales, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Curium Pharmaceuticals
14.6.1 Curium Pharmaceuticals Company Profiles
14.6.2 Curium Pharmaceuticals Product Introduction
14.6.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Jubilant DraxImage
14.7.1 Jubilant DraxImage Company Profiles
14.7.2 Jubilant DraxImage Product Introduction
14.7.3 Jubilant DraxImage Therapeutic Radioisotopes Sales, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Lantheus
14.8.1 Lantheus Company Profiles
14.8.2 Lantheus Product Introduction
14.8.3 Lantheus Therapeutic Radioisotopes Sales, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Spectrum Pharmaceuticals
14.9.1 Spectrum Pharmaceuticals Company Profiles
14.9.2 Spectrum Pharmaceuticals Product Introduction
14.9.3 Spectrum Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Progenics Pharmaceuticals
14.10.1 Progenics Pharmaceuticals Company Profiles
14.10.2 Progenics Pharmaceuticals Product Introduction
14.10.3 Progenics Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 International Isotopes
15. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
